| Literature DB >> 23971008 |
Mária Kazimírová1, Iveta Štibrániová.
Abstract
Ticks require blood meal to complete development and reproduction. Multifunctional tick salivary glands play a pivotal role in tick feeding and transmission of pathogens. Tick salivary molecules injected into the host modulate host defence responses to the benefit of the feeding ticks. To colonize tick organs, tick-borne microorganisms must overcome several barriers, i.e., tick gut membrane, tick immunity, and moulting. Tick-borne pathogens co-evolved with their vectors and hosts and developed molecular adaptations to avoid adverse effects of tick and host defences. Large gaps exist in the knowledge of survival strategies of tick-borne microorganisms and on the molecular mechanisms of tick-host-pathogen interactions. Prior to transmission to a host, the microorganisms penetrate and multiply in tick salivary glands. As soon as the tick is attached to a host, gene expression and production of salivary molecules is upregulated, primarily to facilitate feeding and avoid tick rejection by the host. Pathogens exploit tick salivary molecules for their survival and multiplication in the vector and transmission to and establishment in the hosts. Promotion of pathogen transmission by bioactive molecules in tick saliva was described as saliva-assisted transmission (SAT). SAT candidates comprise compounds with anti-haemostatic, anti-inflammatory and immunomodulatory functions, but the molecular mechanisms by which they mediate pathogen transmission are largely unknown. To date only a few tick salivary molecules associated with specific pathogen transmission have been identified and their functions partially elucidated. Advanced molecular techniques are applied in studying tick-host-pathogen interactions and provide information on expression of vector and pathogen genes during pathogen acquisition, establishment and transmission. Understanding the molecular events on the tick-host-pathogen interface may lead to development of new strategies to control tick-borne diseases.Entities:
Keywords: immunomodulation; pathogen; saliva; ticks; transmission
Mesh:
Substances:
Year: 2013 PMID: 23971008 PMCID: PMC3747359 DOI: 10.3389/fcimb.2013.00043
Source DB: PubMed Journal: Front Cell Infect Microbiol ISSN: 2235-2988 Impact factor: 5.293
Figure 1Hard ticks (Ixodidae) insert their mouthparts into the skin of their hosts and cause tissue injury. Tick mouthparts are anchored in the host skin by a cement cone. At the tick attachment site, a haemorrhagic pool is created. During the prolonged blood-meal ticks secrete a rich cocktail of bioactive salivary molecules to the host and modulate host defence responses (itch, pain, haemostasis, inflammation, immune reactions) to their benefit. The tick salivary cocktail contains molecules (SAT factors) that facilitate pathogen transmission and infection of the host.
Examples of tick salivary molecules that modulate host defence reactions.
| Prostacyclin | Vasodilation | Ribeiro et al., | |
| tHRF | Vasodilation | Dai et al., | |
| IRS-2 | Cathepsin G, chymase | Chmelar et al., | |
| Prostaglandins | Vasodilation | Bowman et al., | |
| Soft ticks (Argasidae) | Apyrase | ATP, ADP | Mans et al., |
| Moubatin | Collagen receptor | Waxman and Connolly, | |
| Disaggregin | Integrin antagonist | Karczewski et al., | |
| Savignygrin | Integrin antagonist | Mans et al., | |
| Apyrase | ATP, ADP | Ribeiro et al., | |
| Ixodegrin | Integrin antagonist | Francischetti et al., | |
| IRS-2 | Thrombin | Chmelar et al., | |
| Longicomin | Collagen receptor | Cheng et al., | |
| Variabilin | Integrin antagonist | Wang et al., | |
| Ornithodorin | Thrombin | Van de Locht et al., | |
| TAP | FXa | Waxman et al., | |
| Savignin | Thrombin | Nienaber et al., | |
| TAP-like protein | FXa | Joubert et al., | |
| Ixolaris | Tissue factor (TF) pathway inhibitor | Francischetti et al., | |
| Salp 14 | Intrinsic pathway | Narasimhan et al., | |
| TIX-5 | Inhibitor FXa-mediated FV activation | Schuijt et al., | |
| Ir-CPI | Intrinsic pathway, fibrinolysis | Decrem et al., | |
| Variegin | Thrombin | Koh et al., | |
| Amblyomin-X | FXa | Batista et al., | |
| Madanin-1; Madanin-2 | Thrombin | Iwanaga et al., | |
| Haemaphysalin | FXII/XIIa | Kato et al., | |
| Longistatin | Fibrinolysis | Anisuzzaman et al., | |
| 65 kDa protein | Prothrombinase complex | Limo et al., | |
| BmAP | Thrombin | Horn et al., | |
| Boophilin | Thrombin, trypsin, plasmin | Macedo-Ribeiro et al., | |
| Microphilin | Thrombin | Ciprandi et al., | |
| Calcaratin | Thrombin | Motoyashiki et al., | |
| OmCI | C5, prevention of interaction of C5 with C5 convertase | Nunn et al., | |
| Isac | Alternative complement pathway, interacts with C3 convertase | Valenzuela et al., | |
| Salp 20 | C3 convertase | Tyson et al., | |
| IRAC I, II, Isac paralogues | Alternative complement pathway, interacts with C3 convertase | Daix et al., | |
| Salp15 | Impairs IL-2 production and T cell proliferation; binds | Anguita et al., | |
| IL-2 binding protein | Inhibits proliferation of human T cells and CTLL-2 cells | Gillespie et al., | |
| ISL 929 and ISL 1373 | Impair adherence of polymorphonuclear leukocytes | Guo et al., | |
| Sialostatin L, L2 | Inhibits cathepsin L activity | Kotsyfakis et al., | |
| Iris | Modulates T lymphocyte and macrophage responsiveness, induces Th2 type responses | Leboulle et al., | |
| BIP | Inhibitor of B cell proliferation | Hannier et al., | |
| Ir-LBP | Impairs neutrophil functions | Beaufays et al., | |
| P36 | T cell inhibitor | Bergman et al., | |
| BIF | Inhibits LPS-induced proliferation of B cells | Yu et al., | |
| Hyalomin A, B | Supresses host inflammatory responses (modulation of cytokine secretion, detoxification of free radicals) | Wu et al., | |
| Japanin | Reprogrammes DC responses | Preston et al., | |
| SHBP | Histamin and serotonin binding protein | Sangamnatdej et al., | |
| RaHBP(M), RaHBP(F) | Histamin binding proteins | Paesen et al., | |
| TdPI | Tryptase inhibitor | Paesen et al., | |
| MIF | Inhibitor of macrophage migration | Jaworski et al., | |
| Ado, PGE2 | Modulate host inflammatory responses | Oliveira et al., | |
| Evasin-1 | Chemokines CCL3, CCL4, CCL18 | Frauenschuh et al., | |
| Evasin-3 | Chemokines CXCL8 and CXCL1 | ||
| Evasin 4 | Chemokines CCL5 and CCL11 | ||
| Metalloprotease | Inhibits angiogenesis | Francischetti et al., | |
| Metalloproteases | Involvement in tissue remodeling or disruption through digestion of structural components | Decrem et al., | |
| Haemangin | Ihibitits angiogenesis | Islam et al., | |
| HLTnI; troponin I-like molecule | Ihibitits angiogenesis | Fukumoto et al., | |
Abbreviatons: tHRF, tick histamine release factor; IRS, I. ricinus serpin; TAP, tick anticoagulant peptide; TIX-5, tick inhibitor of factor Xa toward factor V; Ir-CPI, coagulation contact phase inhibitor from I. ricinus; BmAP, B. microplus anticoagulant protein; SHBP, serotonin- and histamine-binding protein; TdPI, tick-derived peptidase inhibitor; MIF, macrophage migration inhibitory factor; OmCI, O. moubata complement inhibitor; Isac, I. scapularis salivary anticomplement; Irac, I. ricinus anticomplement; Salp, salivary protein; ISL 929 and ISL 1373, I. scapularis salivary proteins 929 and 1373; Iris, I. ricinus immunosuppressor; BIP, B-cell inhibitory protein; P36, 36-kDa immunosuppressant protein; BIF, B-cell inhibitory factor; Ado, adenosine; PGE.
Examples of saliva-assisted transmission of tick-borne pathogens.
| THOV | SGE, enhanced transmission and infectivity | Jones et al., | |
| TBEV | SGE, enhanced transmission and infectivity | Labuda et al., | |
| SGE, accelerating effect on spirochaete proliferation in the host, suppression of proinflammatory cytokines | Pechová et al., | ||
| SGE, accelerating effect on spirochaete proliferation in the host | Macháčková et al., | ||
| Saliva, increased spirochaete load in host skin, increased transmission to ticks | Horká et al., | ||
| SG lysate, increase of spirochaete loads in target organs | Zeidner et al., | ||
| SG lysate, increase of spirochaete loads in target organs | Zeidner et al., | ||
| SGE, accelerates proliferation of the bacteria in the host | Kročová et al., | ||
| THOV | Non-viraemic transmission | Jones et al., | |
| TBEV | Non-viraemic transmission | Labuda et al., | |
| Co-feeding transmission | Richter et al., | ||
| Co-feeding transmission | Gern and Rais, | ||
| Co-feeding transmission | Piesman and Happ, | ||
| TBEV | Saliva, | Fialová et al., | |
| SGE, anti-inflammatory activities | Severinová et al., | ||
| SGE, impairment of signal pathways in DCs | Lieskovská and Kopecký, | ||
| SGE, impairment of DCs functions | Slámová et al., | ||
| Tick feeding, modulation of skin innate immunity | Kern et al., | ||
| BIP, inhibition of B lymphocyte proliferation induced by the | Hannier et al., | ||
| Salp15 Iric-1, a Salp15 homologue, binds to OspC of | Hovius et al., | ||
| Salp15, immunosuppressive functions, binds to OspC of | Ramamoorthi et al., | ||
| Salp25D, antioxidant, facilitates the acquisition of spirochaetes by the vector from an infected mammalian host | Narasimhan et al., | ||
| Salp20, inhibits complement, facilitates pathogen survival | Tyson et al., | ||
| P8, lectin complement pathway inhibitor, facilitates pathogen transmission | Schuijt et al., | ||
| Salp16, facilitates migration of the pathogen to salivary glands | Sukumaran et al., |